SEARCH   
MEMBER LOGIN    

Veterinary Pharmaceutical Manufacturing in Australia: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

Veterinary Pharmaceutical Manufacturing Market Research Report | ANZSIC C1842 | Feb 2014

Man's best friend: Increasing expenditure on companion animals will drive revenue growth

IBISWorld’s Veterinary Pharmaceutical Manufacturing market research report provides the latest industry statistics and industry trends, allowing you to identify the products and customers driving revenue growth and profitability. The industry report identifies the leading companies and offers strategic industry analysis of the key factors influencing the market.

Report Snapshot
Industry Statistics & Market Size
Revenue
$450m
Annual Growth 09-14
-1.7%
Annual Growth 14-19
Add to Cart
Profit
Add to Cart
Employment
925
Businesses
53
Industry Analysis & Industry Trends

The Veterinary Pharmaceutical Manufacturing industry is a relatively small segment of the general Australian pharmaceutical sector. The industry is involved in the development and manufacture of animal health products including veterinary medicines, vaccines, and other biological and medicinal feed additives. As such, it is geared towards two main segments: food producing animals (including cattle, pigs, poultry and sheep) and companion animals (including cats and dogs). In 2011-12, the industry accounted for just 4.4% of the overall pharmaceutical industry.

Over the five years through 2013-14, the performance of the industry was highly volatile as it contended with a number of external shocks... purchase to read more

Industry Report - Industry SWOT Analysis Chapter

Over the past five years, the industry has witnessed some positive growth in both revenue levels and profit as drought conditions have eased and demand for livestock related products has increased. However, the industry's contribution to the economy is expected to grow by just 0.6% on an annualised basis over the 10 years through 2018-19, well below annualised GDP growth during this period, which is expected to be 2.5%. This is occurring as overall pharmaceutical manufacturing continues to de-emphasise animal health operations in Australia, a trend which is expected to continue. ABS data shows that the industry's revenue as a percentage of total pharmaceutical product manufacturing has decreased from 8.3% in 2001-02 to 4.4% in 2011-12... purchase to read more

 


Industry ProductsRelated ReportsTable of Contents

What is the Veterinary Pharmaceutical Manufacturing Industry?

This industry is mainly engaged in manufacturing drugs, medicines, medicinal chemicals, vaccines, serums and other pharmaceutical products for veterinary use. These animal health products are targeted towards food producing animals (cattle, pigs, poultry and sheep) and companion animals (dogs and cats).

Industry Products
ParasiticidesOther productsAntibiotics and related productsImmunotherapy products and vaccinesNutrition and metabolism productsDermatological preparationsMusculosketal system products
 
Industry Activities
ParasiticidesImmunotherapy including vaccinesNutritional and metabolism productAntibioticsOther animal healthcare product


View Sample
Quote
Select Clients